Prulifloxacin

Prulifloxacin
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Overview

Chemical structure of Prulifloxacin

Prulifloxacin is a fluoroquinolone antibiotic used in the treatment of various bacterial infections. It is a prodrug that is converted into its active form, ulifloxacin, in the body. Prulifloxacin is known for its broad-spectrum activity against both Gram-positive and Gram-negative bacteria.

Mechanism of Action

Prulifloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes critical for DNA replication and transcription. This inhibition leads to the disruption of bacterial DNA synthesis, ultimately resulting in bacterial cell death.

Pharmacokinetics

After oral administration, prulifloxacin is rapidly absorbed and converted into ulifloxacin. The active metabolite reaches peak plasma concentrations within a few hours. Prulifloxacin is primarily excreted through the urine, making it effective for treating urinary tract infections.

Clinical Uses

Prulifloxacin is indicated for the treatment of:

• Urinary tract infections
• Respiratory tract infections
• Gastrointestinal infections

Side Effects

Common side effects of prulifloxacin include:

• Nausea
• Diarrhea
• Headache

Serious side effects, although rare, may include tendonitis and tendon rupture, particularly in older adults or those on concurrent corticosteroid therapy.

Contraindications

Prulifloxacin is contraindicated in patients with a known hypersensitivity to fluoroquinolones. It should be used with caution in patients with a history of seizures or epilepsy.

Related pages

• Fluoroquinolone
• Antibiotic
• Bacterial infection